High specificity for MMP-2 and MMP-9 reduces off-target effects and toxicity, providing a more targeted approach to cancer treatment, and these inhibitors also can be used in combination with other therapies, such as chemotherapy, radiation, and immunotherapy, to enhance treatment efficacy. This evidence concerns the gene MMP9 and cancer.